PALMIERI, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 18.722
AS - Asia 10.446
SA - Sud America 6.454
EU - Europa 4.813
Continente sconosciuto - Info sul continente non disponibili 551
AF - Africa 399
OC - Oceania 39
Totale 41.424
Nazione #
US - Stati Uniti d'America 18.277
BR - Brasile 5.737
SG - Singapore 4.969
CN - Cina 2.297
UA - Ucraina 1.329
HK - Hong Kong 967
VN - Vietnam 831
IT - Italia 682
DE - Germania 618
FR - Francia 601
SE - Svezia 423
FI - Finlandia 308
GB - Regno Unito 213
AR - Argentina 207
TR - Turchia 182
CA - Canada 170
MX - Messico 153
BD - Bangladesh 150
IN - India 148
EC - Ecuador 136
IQ - Iraq 134
RU - Federazione Russa 125
ZA - Sudafrica 108
VE - Venezuela 99
MA - Marocco 93
CO - Colombia 86
JP - Giappone 82
UZ - Uzbekistan 79
PL - Polonia 77
PK - Pakistan 69
KR - Corea 68
AT - Austria 66
NL - Olanda 64
ES - Italia 53
PY - Paraguay 50
CL - Cile 49
JO - Giordania 49
KE - Kenya 48
TN - Tunisia 45
ID - Indonesia 44
AZ - Azerbaigian 42
BE - Belgio 40
AE - Emirati Arabi Uniti 39
AU - Australia 36
UY - Uruguay 36
NP - Nepal 31
PE - Perù 30
RO - Romania 28
AL - Albania 27
EU - Europa 27
KZ - Kazakistan 27
JM - Giamaica 25
LT - Lituania 25
OM - Oman 25
DZ - Algeria 24
CZ - Repubblica Ceca 23
LB - Libano 22
EG - Egitto 21
HN - Honduras 21
BO - Bolivia 20
SA - Arabia Saudita 20
KG - Kirghizistan 19
IL - Israele 18
DO - Repubblica Dominicana 17
IR - Iran 16
PH - Filippine 16
RS - Serbia 16
BH - Bahrain 15
SN - Senegal 15
CH - Svizzera 13
PA - Panama 13
SY - Repubblica araba siriana 12
BY - Bielorussia 11
CI - Costa d'Avorio 11
CR - Costa Rica 11
GE - Georgia 11
IE - Irlanda 11
PS - Palestinian Territory 11
BG - Bulgaria 10
GT - Guatemala 10
AM - Armenia 9
NI - Nicaragua 8
XK - ???statistics.table.value.countryCode.XK??? 8
BA - Bosnia-Erzegovina 7
ET - Etiopia 7
MN - Mongolia 7
MY - Malesia 7
PT - Portogallo 7
TT - Trinidad e Tobago 7
A2 - ???statistics.table.value.countryCode.A2??? 6
GR - Grecia 6
KW - Kuwait 6
NG - Nigeria 6
AO - Angola 5
BN - Brunei Darussalam 5
HU - Ungheria 5
LK - Sri Lanka 5
MD - Moldavia 5
DK - Danimarca 4
LV - Lettonia 4
Totale 40.855
Città #
Dallas 6.126
Singapore 2.728
Chandler 2.350
San Jose 1.463
Hong Kong 953
Ashburn 811
Princeton 768
Jacksonville 661
Council Bluffs 549
Columbus 500
Beijing 435
São Paulo 393
Lauterbourg 373
Ho Chi Minh City 306
Wilmington 288
Dearborn 276
Nanjing 262
Shanghai 251
Santa Clara 204
Hanoi 195
Belo Horizonte 172
New York 165
Los Angeles 159
Rio de Janeiro 158
Ann Arbor 151
Helsinki 141
Boardman 125
Brasília 113
Nanchang 112
Sassari 109
Orem 88
Porto Alegre 82
Curitiba 81
Campinas 80
Frankfurt am Main 80
Tokyo 79
The Dalles 74
Tianjin 72
Seoul 67
Tashkent 67
Nuremberg 65
San Francisco 62
Warsaw 62
Shenyang 61
Norwalk 56
Changsha 55
Guarulhos 54
Johannesburg 54
Hebei 53
Baghdad 52
Jiaxing 51
Toronto 49
Amman 48
Da Nang 48
Goiânia 47
Montreal 47
Milan 45
Osasco 44
Chicago 43
Brooklyn 42
Chennai 42
Mexico City 42
Munich 42
Nairobi 42
Salvador 42
Guayaquil 41
Ribeirão Preto 41
Santo André 40
Brussels 39
Dhaka 39
Istanbul 39
Fortaleza 38
Buffalo 37
Atlanta 36
Manaus 36
Mountain View 36
Quito 36
Falls Church 35
Haiphong 35
Stockholm 35
Vienna 35
Woodbridge 35
Betim 34
Amsterdam 33
Baku 33
Caxias do Sul 33
Joinville 33
Sorocaba 33
São Bernardo do Campo 33
Ankara 32
Cagliari 32
London 32
Recife 32
Campo Grande 31
Kunming 31
Denver 29
Juiz de Fora 29
Pelotas 29
Poplar 29
Falkenstein 28
Totale 24.514
Nome #
Clinical, Histopathological, Dermoscopic Features, and BRAF, NRAS, and Cell Cycle Genes’ Mutation Status in Cutaneous Melanoma 1.170
A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis 350
KRAS mutations in Non-Small Cell Lung Cancer: translational aspects, current therapies and challenges for future research 313
Allelic Gains And Losses At 10q25-Q26 In Malignancies Of The Uterine Corpus: Demonstration Of Two Distinctive Genetic Alterations 283
EGFR mutation detection in Whole Slide Images of non-small cell lung cancers using a two-stage deep transfer learning approach 268
Aspetti epidemiologici dei tumori maligni dell’ovaio nel Nord Sardegna nel periodo 1992-2001 255
Analysis of fanconi anemia genes in colorectal cancer 210
A Founder Mutation In Sardinian Breast Cancer Families Detected By Identity-By-Descent Method 198
Analysis of the mapk-erk gene pathway in primary and metastatic melanoma cell lines 197
A role of BRCA1 and BRCA2 germline mutations in breast cancer susceptibility within Sardinian population 195
Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas 192
KIT and PDGFRa mutational patterns in Sardinian patients with gastrointestinal stromal tumors 192
Analysis of candidate genes through a proteomics-based approach in primary cell lines from malignant melanomas and their metastases 191
A novel candidate gene in human endometrial cancer at chromosome 10q26 184
Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humans 181
Breast cancer incidence and mortality in North Sardinia in the period 1992 - 2010 180
Dermoscopy and confocal microscopy for metachronous multiple melanomas: morphological, clinical, and molecular correlations 180
Deciduoid mesothelioma of the thorax: A comprehensive review of the scientific literature 175
Epidemiology of thyroid cancer in an area of epidemic thyroid goiter 175
CASC2a gene is down-regulated in endometrial cancer 170
Breast Nodular Fasciitis: A Comprehensive Review 168
A Diagnostic of Acquired Hemophilia Following PD1/PDL1 Inhibitors in Advanced Melanoma: The Experience of Two Patients and a Literature Review 167
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study 167
Long non-coding RNA CASC2 in human cancer 167
Are Molecular Alterations Linked to Genetic Instability Worth to Be Included as Biomarkers for Directing or Excluding Melanoma Patients to Immunotherapy? 166
Comparison of BRAF Mutation Screening Strategies in a Large Real-Life Series of Advanced Melanoma Patients 164
EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1,440 Sardinian patients with lung adenocarcinoma. 160
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis 160
Phenotype characterization of human melanoma cells resistant to dabrafenib 158
Disease progression and overall survival in sardinian patients with colorectal cancer according to the kras mutational status 152
Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach 151
Breast cancer incidence and mortality in North Sardinia in the period 1992–2010 148
Female Adnexal Tumors of Probable Wolffian Origin (FATWO): A Case Series with Next-Generation Sequencing Mutation Analysis 147
Genetic alterations in main candidate genes during melanoma progression 145
Dietary compounds and cutaneous malignant melanoma: recent advances from a biological perspective 143
Colorectal cancer epidemiology in an area with a spontaneous screening program 142
Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study 142
Global prognostic impact of driver genetic alterations in patients with lung adenocarcinoma: a real-life study 142
Presence of Jaagsiekte sheep retrovirus in tissue sections from human bronchioloalveolar carcinoma depends on patients' geographical origin 142
Fanconi genes may contribute to melanoma pathogenesis 142
Fanconi genes are altered in subsets of patients with sporadic colorectal carcinoma 141
Epidemiology and genetic susceptibility of malignant melanoma in North Sardinia, Italy 141
Genetic Instability Markers in Cancer 140
BRAF mutations and dysregulation of the MAP kinase pathway associated to sinonasal mucosal melanomas 139
Microsatellite analysis at 10q25-q26 in Sardinian patients with sporadic endometrial carcinoma - Identification of specific patterns of genetic alteration 138
Cytogenetic assessment of the involvement of a new locus at 9p21 in malignant melanoma 137
Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma 136
Repurposing anticancer drugs for the treatment of idiopathic pulmonary fibrosis and antifibrotic drugs for the treatment of cancer: state of the art 136
Mutation analysis of mucosal and cutaneous melanomas during progression 135
Adjuvant therapy of cutaneous melanoma 135
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: A survey of young oncologists 134
Adjuvant treatment of malignant melanoma: where are we? 133
Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy 133
Head and neck cancer epidemiology in North Sardinia, Italy. 132
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI) 132
Molecular classification of patients with malignant melanoma for new therapeutic strategies 131
Antitumoral effect of vanadium compounds in malignant melanoma cell lines 129
KRAS mutational concordance between primary and metastatic colorectal adenocarcinoma 129
Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assay 129
X-inactivation patch size in human female tissue confounds the assessment of tumor clonality 127
Epidemiology of malignant pleural mesothelioma in the province of Sassari (Sardinia, Italy). A population-based report 125
2,2’-dihydroxy-3,3’-dimethoxy-5,5’-dimethyl-6,6’-dibromo-1,1’-biphenyl: preparation, resolution, structure and biological activity 125
Uterine perivascular epithelioid cell neoplasms (PEComas): Report of two cases and literature review 125
Epidemiological aspects of ovarian malignancies in North Sardinia in the period 1992-2001 124
Protein expression changes induced in a malignant melanoma cell line by the curcumin analogue compound D6 124
Molecular epidemiology of the main druggable genetic alterations in non-small cell lung cancer 124
Microsatellite analysis at 10q25-q26 in Sardinian patients with sporadic endometrial carcinoma 123
Antiproliferative and pro-apoptotic activity of eugenol-related biphenyls on malignant melanoma cells 123
BRCA1 and BRCA2 mutation analysis in breast cancer families from Sardinia 121
Microsatellite and fish analysis in endometrial cancer: Assessment of specific patterns of genetic and cytogenetic alterations with their clinical correlations 121
Mutational analysis of candidate genes in families with malignant melanoma (MM): assessment of the role of the CDKN2A gene in MM predispositions 121
Human gene mutations gene symbol: BRCA2 small insertion in breast cancer 121
Antiproliferative activity of vanadium compounds: Effects on the major malignant melanoma molecular pathways 121
Actin-binding protein (ABP-280) filamin gene maps telomeric to the color vision locus (R/GCP) and centromeric to G6PD in Xq28. 120
The effect of COVID-19 emergency in the management of melanoma in Italy 120
Primary dermal melanoma in a patient with a history of multiple malignancies: a case report with molecular characterization 119
Immunohistochemistry and biomolecular investigation for the evidence of JSRV-like retrovirus in human bronchiolo-alveolar carcinomas 119
An evaluation of talazoparib plus enzalutamide for the treatment of metastatic castration-resistant prostate cancer 119
Germline mutations in candidate genes among patients with cutaneous melanoma from Sardinia 118
Squamous cell carcinoma arising in mature cystic teratoma of the ovary: report of two cases with molecular analysis 118
Screening for founder mutations in BRCA1/2 tumor susceptibility genes among breast cancer families from North Sardinia 118
A Role ofBRCA1andBRCA2germline mutations in breast cancer susceptibility within Sardinian population 117
Origin and distribution of the BRCA2-8765delAG mutation in breast cancer 117
Assessment of genetic instability in melanocytic skin lesions through microsatellite analysis of benign naevi, dysplastic naevi, and primary melanomas and their metastases 116
A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation 116
Pancreatic cancer burden in North Sardinia, Italy 116
Indagini immunoistochimiche e biomolecolari per l’evidenziazione di retrovirus jsrv-correlati, in carcinomi bronchiolo-alveolari dell’uomo 116
1.5-Mb YAC contig in Xq28 formatted with sequence-tagged sites and including a region unstable in the clones 116
BRAF and PIK3CA genes are somatically mutated in hepatocellular carcinoma among patients from South Italy 115
Identification of different patterns of genetic alteration (a new minimal LOH region at chromosome 10q25-26 and genomic instability) in Sardinian patients with sporadic endometrial cancer and correlation with clinicopathological parameters 115
Primary melanoma of the lung: A systematic review 113
3-year treatment with recombinant interferon- as adjuvant therapy of cutaneous malignant melanoma. 113
An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival 113
Synchronous interdigitating dendritic cell sarcoma and B-cell small lymphocytic lymphoma in a lymph node 112
Assessment of the role of Fanconi Anemia (FA) genes in colorectal cancer: A new pathogenetic pathway? 112
Assessment of microsatellite instability in benign nevi, dysplastic nevi, and primary melanomas along with their metastases 112
Anticancer activity of two novel hydroxylated biphenyl compounds toward malignant melanoma cells 112
4-Substituted-2-Methoxyphenol: Suitable Building Block to Prepare New Bioactive Natural-like Hydroxylated Biphenyls 112
Low Levels of Genetic Heterogeneity in Matched Lymph Node Metastases from Patients with Melanoma 111
Enhanced anti-tumor activity of a newcurcumin-related compound against melanoma and neuroblastoma cells 111
Totale 15.733
Categoria #
all - tutte 185.227
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 185.227


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.441 0 8 7 28 21 35 81 129 144 130 171 687
2022/20234.418 431 204 76 818 370 874 2 493 803 36 187 124
2023/20241.088 260 119 29 36 125 81 26 109 3 19 93 188
2024/202511.568 93 83 657 213 405 510 489 2.503 4.350 1.556 427 282
2025/202616.720 465 5.038 2.153 2.074 1.574 931 2.281 473 690 605 289 147
2026/20271.336 338 998 0 0 0 0 0 0 0 0 0 0
Totale 41.424